Skip To Main Content
Elena A. Parshina on Muck Rack

Elena A. Parshina

As seen in: JAMA Network, Cell Reports
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elena A.

Contact Elena A., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Management of Exacerbations and Rescue Therapy : A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial

|
By Richard J. Nowak, Kimiaki Utsugisawa, Michael Benatar, Emma Ciafaloni, M. Isabel Leite, John Vissing, Fengming Tang, Yanping Wu, Catherine E Najem, Sue Cheng, James Howard, Conrado J. Estol, Florencia Aguirre, Alexandre Guerreiro, WIlson Marques Júnior, Wilson Marques Junior, Vera Bril, Xinghu Zhang, Dian He, Lan Chu, Chongbo Zhao, Yuwei Da, Qi Fang, Jing Li, Ting Chang, Sabrina Sacconi, Aleksandra Nadaj-Pakleza, Tim Hagenacker, Praveen Kumar S, Jayantee Kalita, Rukmini M. Kandadai, Neeharika L Mathukumalli, Raffaele Iorio, Renato Mantegazza, Carlo Antozzi, Akiyuki Uzawa, Yasushi Suzuki, Masako Suzuki, Takayuki Kondo, Anetta Lasek-Bal, Joanna Siuda, Karolina Piasecka-Stryczynska, Elena A. Parshina, Irina Poverennova, Byoung Joon Kim, Jeeyoung Oh, Alicia Martínez Piñeiro, Eduardo Morales, Long-Sun Ro, Jiann-Horng Yeh, Nai-Wen Tsai, Yuan-Ting Sun, Yi-Chung Lee, Chen-Chih Chung, Ayşe Nur YÜCEYAR, Ihsan Sukru Sengun, Aziz Shaibani, Waqar Waheed, Tuan Hoang Vu, Kelly G. Gwathmey, Ratna K. Bhavaraju-Sanka, Ali A Habib, Urvi Desai, Yessar Hussain, Nicholas S. Streicher, Ryan Drake, Marcelo Rugiero, Halina Navumava, Ruslan Yakubtsevich, Yury Holets, Marcelo V. Raffo, Eduardo Estephan, Fudong Shi, Anirudha Apte, Rahul Baviskar, Arvind N. N. Prabhu, Ruhal Kulkarni, Surya Prabha Turaga, Sanjay Ramteke, Genya Watanabe, Andrej Szczudlik, Małgorzata Zajda, Denis Korobko, Evgeny Evdoshenko, Zoya Goncharova, Yury Trinitatskiy, Klara Bakhtiyarova, Inna Smagina, Hsuah-Wen Hseuh, Olga Shulga, Oleksandr Doroshenko, Sergii Moskovko, Oleksandr Kalbus, George A. Small
| JAMA Network Verified
Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial Supplement 1. Supplement 2. eFigure 1. Number of Participants with Defined Components of Exacerbation during the MINT RCP eFigure 2. Annualized Exacerbation Rate eFigure 3. Swimmer Plots of Participants with Exacerbation during the MINT RCP eTable. Time to First Exacerbation by Week 26 (Full Analysis Set: MuSK+ Subpopulation) Supplement 3. Figure 1.
Open in Who Shared Issue with article?

Cytoskeletal Protein Zyxin Inhibits the Activity of Genes Responsible for Embryonic Stem Cell Status

|
By Fedor M. Eroshkin, Elena A. Parshina, Fatima K. Gyoeva
| Cell Reports Verified
Highlights • Zyxin inhibits the activity of pou5f3 genes responsible for embryonic stem cell status • Ybx1 binds pou5f3 mRNA, thus increasing its stability • Zyxin directly binds to Ybx1 and holds it in the cytoplasm • Zyxin reduces stability of pou5f3 mRNA by interfering with its binding to Ybx1 Summary Zyxin is a cytoskeletal LIM-domain protein that regulates actin cytoskeleton assembly and gene expression.
Open in Who Shared Issue with article?
See all 2 articles